澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ORTHOCELL LTD

0.985

+0.0505.35%

成交量：51.48萬

成交額：50.28萬

市值：2.67億

市盈率：-25.67

高：0.995

開：0.950

低：0.940

收：0.935

52周最高：1.730

52周最低：0.855

股本：2.71億

流通股本：1.94億

量比：1.69

換手率：0.27%

股息：- -

股息率：- -

每股收益(TTM):-0.038

每股收益(LYR):-0.038

淨資產收益率：-89.70%

總資產收益率：-26.42%

市淨率：18.33

市盈率(LYR):-25.67

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+1.81%

資金流向

資金流入：

資金流出：

新聞資訊

Orthocell Ltd 增持Marine Biomedical股權至11.7%，總投資額達105萬澳元

ORTHOCELL LTD - 提交監管申請以在歐盟和英國神經修復市場上商業分銷Remplir

上屆喊單王 Murad：2026 年牛市會來的 116 個理由

Orthocell Ltd 增加對 Marine Biomedical 的股權至 12.0%，總代價為 100 萬澳元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OCC.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","market":"AU","secType":"STK","nameCN":"ORTHOCELL LTD","latestPrice":0.985,"timestamp":1770696237013,"preClose":0.935,"halted":0,"volume":514832,"delay":0,"changeRate":0.05347593582887693,"nameEN":"ORTHOCELL LTD","floatShares":194076512,"shares":271090199,"eps":-0.03837,"marketStatus":"交易中","change":0.05,"latestTime":"02-10 15:06:56 AEDT","open":0.95,"high":0.995,"low":0.94,"amount":502785,"amplitude":0.058824,"askPrice":0.99,"askSize":4745,"bidPrice":0.98,"bidSize":6611,"shortable":3,"etf":0,"ttmEps":-0.03837,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.935,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.694146,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","floatShares":194076512,"roa":"-26.42%","roe":"-89.70%","lyrEps":-0.03837,"volumeRatio":1.694146,"shares":271090199,"dividePrice":0,"high":0.995,"amplitude":0.058824,"preClose":0.935,"low":0.94,"week52Low":0.855,"pbRate":"18.33","psRate":"35.36","week52High":1.73,"institutionHeld":0,"latestPrice":0.985,"committee":0.164318,"eps":-0.03837,"divideRate":0,"volume":514832,"delay":0,"ttmEps":-0.03837,"open":0.95,"prevYearClose":1.085,"prevWeekClose":0.91,"prevMonthClose":0.92,"prevQuarterClose":1.085,"fiveDayClose":0.955,"twentyDayClose":1.06,"sixtyDayClose":1.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCC.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150494114","title":"Orthocell Ltd 增持Marine Biomedical股權至11.7%，總投資額達105萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150494114","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150494114?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 06:05","pubTimestamp":1768514717,"startTime":"0","endTime":"0","summary":"再生医学公司Orthocell Ltd宣布，已将其在海洋生物医药公司Marine Biomedical的持股比例提升至11.7%。此次增持使Orthocell对该公司的累计投资总额达到105万澳元。该举措进一步深化了双方在创新生物医学领域的战略合作，有望为Orthocell的产品管线注入新的技术资源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","OCC.AU","BK7508"],"gpt_icon":0},{"id":"1129794615","title":"ORTHOCELL LTD - 提交監管申請以在歐盟和英國神經修復市場上商業分銷Remplir","url":"https://stock-news.laohu8.com/highlight/detail?id=1129794615","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129794615?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 06:07","pubTimestamp":1765750031,"startTime":"0","endTime":"0","summary":"ORTHOCELL LTD - 提交监管申请以在欧盟和英国神经修复市场上商业分销Remplir","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OCC.AU","BK7067"],"gpt_icon":0},{"id":"2588951833","title":"上屆喊單王 Murad：2026 年牛市會來的 116 個理由","url":"https://stock-news.laohu8.com/highlight/detail?id=2588951833","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588951833?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 23:00","pubTimestamp":1764860416,"startTime":"0","endTime":"0","summary":" “我并不认同市场周期仅为四年的观点，我认为这一周期可能会延长至四年半甚至五年，并可能持续到 2026 年。” ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2226389","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETH","OI","BTC","09042","03008","03042","BK4594","BK4550","BK7067","BK4126","BTC.USD.HKCC","OCC","09008","BK4020","BK4585","OCC.AU","FDN","BK4588","03439","09439","BK1611","MBTmain","BTC.USD.CC","83042","BK7508","BK4601"],"gpt_icon":1},{"id":"1149412243","title":"Orthocell Ltd 增加對 Marine Biomedical 的股權至 12.0%，總代價為 100 萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149412243","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149412243?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 05:59","pubTimestamp":1760911141,"startTime":"0","endTime":"0","summary":"Orthocell Ltd 增加对 Marine Biomedical 的股权至 12.0%，总代价为 100 万澳元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCC.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OCC.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.018076}]}}